Your browser doesn't support javascript.
loading
Portal Hypertension in Children: A Tertiary Center Experience in Turkey.
Sunar Yayla, Emine Nur; Sari, Sinan; Gürcan Kaya, Neslihan; EgrItas Gürkan, Ödül; Sözen, Hakan; Özen, Ibrahim Onur; Dalgiç, Aydin; Dalgiç, Buket.
Afiliación
  • Sunar Yayla EN; Department of Pediatrics, Faculty of Medicine, Gazi University, Ankara, Turkey.
  • Sari S; Department of Pediatrics, Division of Pediatric Gastroenterology, Faculty of Medicine, Gazi University, Ankara, Turkey.
  • Gürcan Kaya N; Department of Pediatrics, Division of Pediatric Gastroenterology, Faculty of Medicine, Gazi University, Ankara, Turkey.
  • EgrItas Gürkan Ö; Department of Pediatrics, Division of Pediatric Gastroenterology, Faculty of Medicine, Gazi University, Ankara, Turkey.
  • Sözen H; Division of Transplantation Surgery, Faculty of Medicine, Gazi University, Ankara, Turkey.
  • Özen IO; Department of Pediatric Surgery, Faculty of Medicine, Gazi University, Ankara, Turkey.
  • Dalgiç A; Division of General Surgery, Faculty of Medicine, Gazi University, Ankara, Turkey.
  • Dalgiç B; Department of Pediatrics, Division of Pediatric Gastroenterology, Faculty of Medicine, Gazi University, Ankara, Turkey.
Pediatr Gastroenterol Hepatol Nutr ; 26(6): 301-311, 2023 Nov.
Article en En | MEDLINE | ID: mdl-38025487
Purpose: Portal hypertension (PH) and its complications have a significant impact on morbidity and mortality. This study aimed to evaluate the etiology; clinical, laboratory, and endoscopic findings; treatment approaches; long-term outcomes; and prognosis of pediatric PH. Methods: This retrospective study included 222 pediatric patients diagnosed with PH between 1998 and 2016, and data encompassing clinical, laboratory, and radiological features; treatments; and complications were analyzed. Results: The most common causes of PH were portal vein thrombosis (20.3%), progressive familial intrahepatic cholestasis (18.9%), and biliary atresia (12.2%). Among the enrolled patients, 131 (59.0%) were included in the cirrhotic group and 91 (41.0%) in the non-cirrhotic group. Hepatomegaly and increased transaminase levels were more frequent in the cirrhotic group than in the non-cirrhotic group. Additionally, portal gastropathy, esophageal varices, and variceal bleeding were more frequent in the non-cirrhotic group, whereas ascites, hepatopulmonary syndrome and hepatic encephalopathy were more common in the cirrhotic group. The incidence of hepatomegaly was higher in the presinusoidal group than in the prehepatic group (p<0.001). Hyperbilirubinemia was more frequent in the prehepatic group (p=0.046). The frequency of esophageal varices was similar between the prehepatic and presinusoidal groups; however, variceal bleeding was more frequent in the prehepatic group (p=0.002). Conclusion: Extrahepatic portal vein obstruction, genetic-metabolic diseases, and biliary atresia were the most prevalent causes of PH in our country. In patients with PH, hepatomegaly, increased transaminase levels, and synthesis dysfunction were suggestive of cirrhotic PH. Notably, PH in patients without cirrhosis might be more severe than that in those with cirrhosis.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Pediatr Gastroenterol Hepatol Nutr Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Pediatr Gastroenterol Hepatol Nutr Año: 2023 Tipo del documento: Article